Trial NCT04023071

View at ClinicalTrials.gov 
Org. Study IDs: FT516-101

Last trial update was posted on 2023-10-26

MeSH Interventions

Bendamustine Hydrochloride Cyclophosphamide Fludarabine Obinutuzumab Rituximab

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Lymphoma Lymphoma, B-Cell

Other Conditions

Acute Myelogenous Leukemia B-cell Lymphoma

Stopping Reasons

The study was terminated by the Sponsor.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID